• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

REVISION OPTICS RAINDROP NEAR VISION INLAY; CORNEAL INLAY Back to Search Results
Model Number 610-0001
Device Problems Improper or Incorrect Procedure or Method (2017); Device Dislodged or Dislocated (2923)
Patient Problems Corneal Scar (1793); Corneal Clouding/Hazing (1878); Keratitis (1944); Visual Impairment (2138); Burning Sensation (2146)
Event Date 10/28/2016
Event Type  Injury  
Manufacturer Narrative
The device history record (dhr) for this manufacturing lot was reviewed and the device met all release criteria and there were no discrepancies or unusual findings that relate to the reported event.Inlay decentration is listed in the device labeling as a known complication of corneal inlay surgery.Dlk is also listed in the device labeling and is commonly associated with corneal flap procedures.The instructions for use for the raindrop near vision inlay specifies that the corneal flap must be a minimum of 150 microns thick; however, the patient's flap was only 120 microns.The flap thickness and off-label use of celluvisc may have been contributory to the reported issues.(b)(4).Date emdr submitted to fda: 12/15/2016.
 
Event Description
Corneal inlay implantation was performed on (b)(6) 2016 on the patient's left eye.During corneal flap creation using a femtosecond laser, the patient inadvertently received a flap thickness of 120 microns even though the surgeon ordered 180 microns.At the end of the procedure, several drops of celluvisc were instilled on the flap.At the one-day postoperative visit, the patient complained of blurry vision and stinging sensation.The inlay had decentered slightly inferiorly and the patient was diagnosed with trace diffuse lamellar keratitis (dlk).The postoperative steroid regimen included durezol and vigamox and artificial tears as needed.The patient's preoperative best corrected distance visual acuity (bcdva) was 20/20.New information was received on (b)(6) 2015 indicating that the inlay will be explanted due to decentration.Additional information was requested and on (b)(6) 2016 the surgeon provided the following update.At onset, the patient's postoperative bcdva decreased to 20/50, but improved to 20/15 on (b)(6) 2016.On (b)(6) 2016, the flap was irrigated and the inlay was removed and replaced with a new inlay in order to address both dlk and inlay decentering, which was described as slightly inferior.The dlk resolved.
 
Manufacturer Narrative
The explanted inlay was returned to the manufacturer and subjected to visual microscopic inspection.The findings revealed that the inlay was folded and dehydrated.As a result, no dimensional measurements could be performed.Complaint (b)(4).Date esmdr submitted: 03/02/2017, reference mdr# 3005956347-2017-00004 for the replacement inlay.
 
Event Description
An adverse event occurred with the replacement raindrop corneal inlay that was implanted in the patient's left eye on (b)(6) 2016.Reference mdr# 3005956347-2017-00004 which was filed for the replacement inlay for this same patient.
 
Manufacturer Narrative
(b)(4).Reference mdr# 3005956347-2017-00004 for the events involving the second inlay.
 
Event Description
The following new information was provided on july 26, 2017.At last examination on (b)(6) 2017, the patient's bcdva improved to 20/20 with trace central corneal haze and minimal epithelial in-growth.There is no further patient follow-up scheduled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAINDROP NEAR VISION INLAY
Type of Device
CORNEAL INLAY
Manufacturer (Section D)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer (Section G)
REVISION OPTICS
25651 atlantic ocean dr.,
ste. a1
lake forest CA 92630 8835
Manufacturer Contact
pushpita singh
25651 atlantic ocean dr.,
ste. a1
lake forest, CA 92630-8835
9497072740
MDR Report Key6179681
MDR Text Key62525316
Report Number3005956347-2016-00010
Device Sequence Number1
Product Code LQE
UDI-Device Identifier10850394006013
UDI-Public(01)10850394006013(17)190808(10)002979
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 07/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/08/2019
Device Model Number610-0001
Device Catalogue NumberRD1-1
Device Lot Number002979
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer12/27/2016
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received07/26/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number3005956347-02/03/17-001
Patient Sequence Number1
Treatment
CELLUVISC ARTIFICIAL TEARS; FEMTOSECOND LASER FOR CREATION OF CORNEAL FLAP
Patient Outcome(s) Required Intervention;
Patient Age46 YR
-
-